US5278151A
(en)
*
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
US5364632A
(en)
*
|
1989-04-05 |
1994-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Medicinal emulsions
|
AU655919B2
(en)
*
|
1990-02-22 |
1995-01-19 |
Macnaught Pty Limited |
Artificial tears
|
ZA912797B
(en)
*
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
ATE132366T1
(de)
*
|
1990-05-29 |
1996-01-15 |
Boston Ocular Res |
Zusammensetzung zur behandlung von dry eye erkrankungen
|
FR2673513B1
(fr)
*
|
1991-03-05 |
1993-10-29 |
Institut Recherche Biologique Sa |
Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
|
ZA927277B
(en)
*
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
US5290572A
(en)
*
|
1992-08-06 |
1994-03-01 |
Deo Corporation |
Opthalmic composition for treating dry eye
|
US5830508A
(en)
*
|
1992-08-06 |
1998-11-03 |
Deo Corporation |
Composition for treating dry eye
|
SG49746A1
(en)
*
|
1992-08-28 |
1998-06-15 |
Pharmos Corp |
Submicron emulsions as ocular drug delivery vehicles
|
TW274516B
(de)
*
|
1993-11-12 |
1996-04-21 |
Ciba Geigy Ag |
|
DE69629230D1
(de)
*
|
1995-03-24 |
2003-09-04 |
Ocular Res Of Bonton Inc |
Hydrogellinse mit Lipid-Vorbeschichtigung
|
DE19511322C2
(de)
|
1995-03-28 |
1999-09-02 |
Mann Gerhard Chem Pharm Fab |
Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
|
US5616342A
(en)
*
|
1995-04-11 |
1997-04-01 |
Pdt, Inc. |
Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
|
US5696166A
(en)
*
|
1995-10-31 |
1997-12-09 |
Yanni; John M. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
US5738856A
(en)
*
|
1995-11-03 |
1998-04-14 |
Ocular Research Of Boston, Inc. |
Skin care preparation and method
|
IL120005A
(en)
|
1997-01-14 |
2000-08-31 |
Ramot University Authority Of |
Pharmaceutical compositions for the treatment of the eye
|
ZA989513B
(en)
|
1997-10-21 |
1999-04-21 |
Alcon Lab Inc |
Compositions containing histamine H2 agonists and methods of use in treating dry eye
|
EP0982025A1
(de)
*
|
1998-08-28 |
2000-03-01 |
Wilhelm Prof. Dr. Stoffel |
Künstliche Tränen
|
AU2183900A
(en)
|
1998-12-24 |
2000-07-31 |
Alcon Laboratories, Inc. |
Ep4 receptor agonists for treatment of dry eye
|
US6462080B1
(en)
|
1998-12-24 |
2002-10-08 |
Alcon Manufacturing, Ltd. |
Prostaglandin E receptor agonists for treatment of dry eye
|
US6429194B1
(en)
*
|
1999-03-01 |
2002-08-06 |
Vista Scientific Llc |
Mucin containing ophthalmic preparation
|
US6281192B1
(en)
|
1999-03-01 |
2001-08-28 |
Vista Scientific Llc |
Mucin containing ophthalmic preparations
|
US6552084B2
(en)
|
1999-11-09 |
2003-04-22 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
US6342525B1
(en)
|
1999-11-09 |
2002-01-29 |
Alcon Universal Ltd. |
Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
|
BR0015404A
(pt)
|
1999-11-09 |
2002-06-25 |
Alcon Inc |
Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso
|
AU776146B2
(en)
|
1999-11-09 |
2004-08-26 |
Alcon Inc. |
3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use
|
DE60019322T2
(de)
|
1999-11-09 |
2005-09-08 |
Alcon Inc. |
Heteroatomunterbrochene analoge von15-hydroxyeicosatetraensäure und verfahren zu deren verwendung
|
AU1101301A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
|
CA2386878A1
(en)
|
1999-11-09 |
2001-05-17 |
Peter G. Klimko |
Lipoxin a4 and its analogs for the treatment of dry eye
|
ES2242643T3
(es)
|
1999-11-09 |
2005-11-16 |
Alcon Inc. |
Sales de hidroxieicosatetraenoato, composiciones y metodos de uso en el tratamiento de trastornos del ojo seco.
|
US6803385B2
(en)
|
1999-11-09 |
2004-10-12 |
Alcon, Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
US6458854B2
(en)
|
1999-11-09 |
2002-10-01 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
DK1228031T3
(da)
|
1999-11-09 |
2004-04-13 |
Alcon Inc |
Omegakædemodificerede 15-hydroxyeicosatetraensyrederivater, der er egnede til behandling af øjentørhed
|
US6353032B1
(en)
|
1999-11-09 |
2002-03-05 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
US6320062B1
(en)
|
1999-11-09 |
2001-11-20 |
Alcon Universal Ltd. |
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
|
CA2386619A1
(en)
|
1999-11-09 |
2001-05-17 |
Alcon, Inc. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
US6576663B2
(en)
|
1999-12-22 |
2003-06-10 |
Alcon, Inc. |
6-Keto prostaglandin F1α and analogs for treating dry eye
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
DE60213230T2
(de)
|
2001-05-21 |
2006-11-23 |
Alcon Inc. |
Verwendung von NF-Kappa.B Inhibitoren zur Behandlung von Augentrockenheit
|
US20030008853A1
(en)
*
|
2001-05-21 |
2003-01-09 |
Alcon, Inc. |
Method for treating dry eye disorders
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
AU2002308760B2
(en)
|
2001-05-21 |
2006-05-11 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
US6750250B1
(en)
|
2001-07-12 |
2004-06-15 |
Alcon, Inc. |
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
|
DE10141018A1
(de)
*
|
2001-08-22 |
2003-03-13 |
Eth Zuerich Eidgenoessische Te |
Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
WO2003030892A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
US20030109508A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Alcon, Inc. |
Methods for treating dry eye
|
EP1438037A1
(de)
*
|
2001-10-11 |
2004-07-21 |
Alcon, Inc. |
Verfahren zur behandlung des trockenen auges mit einer kombination eines entzündungshemmenden steroids mit einem muc-1-sekretagogon
|
US6656460B2
(en)
|
2001-11-01 |
2003-12-02 |
Yissum Research Development |
Method and composition for dry eye treatment
|
CN100469776C
(zh)
*
|
2002-05-17 |
2009-03-18 |
奥特拉控股公司 |
白内障和其它眼病发展的改善
|
US7897642B1
(en)
*
|
2002-06-19 |
2011-03-01 |
Dr. Irvine Dubow |
Compositions and methods for dry eye syndrome
|
US8420699B1
(en)
|
2002-06-19 |
2013-04-16 |
Irvine L. Dubow |
Composition and methods of treatment using deionized and ozonated solution
|
PL374700A1
(en)
*
|
2002-09-20 |
2005-10-31 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
EP1551417B1
(de)
*
|
2002-10-18 |
2008-09-10 |
Joel S. Echols |
Dreischichtige tränenformulierung
|
US7051156B2
(en)
|
2002-11-06 |
2006-05-23 |
Synology Inc. |
Raid-5 disk having cache memory
|
US20060217325A1
(en)
*
|
2002-12-20 |
2006-09-28 |
Alcon, Inc. |
Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells
|
WO2004093878A1
(en)
*
|
2003-04-16 |
2004-11-04 |
Alcon, Inc. |
Use of fused pyridazine derivatives for treating dry eye disorders
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
US20050182039A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Bausch & Lomb Incorporated |
Use of Loteprednol etabonate for the treatment of dry eye
|
US8455016B2
(en)
|
2004-03-12 |
2013-06-04 |
Melbj Holdings, Llc |
Treatment for meibomian gland dysfunction or obstruction
|
US20050202097A1
(en)
*
|
2004-03-12 |
2005-09-15 |
Melbj Holdings, Llc, Florida |
Lubricant for the ocular surface
|
AU2005229006B9
(en)
|
2004-03-25 |
2011-05-19 |
Bausch & Lomb Incorporated |
Use of loteprednol etabonate for the treatment of dry eye
|
US20050256189A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
US20070265341A1
(en)
*
|
2004-07-01 |
2007-11-15 |
The Schepens Eye Research Institute Inc. |
Compositions and methods for treating eye disorders and conditions
|
RU2007103835A
(ru)
*
|
2004-07-01 |
2008-08-10 |
Шепенс Ай Рисерч (Us) |
Композиции и способы лечения заболеваний и нарушений состояния глаз
|
US7223737B1
(en)
|
2004-08-13 |
2007-05-29 |
Alcon, Inc. |
Method of treating dry eye disorders using glycosides
|
WO2006065916A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(s)-hode and its analogs
|
US9161905B2
(en)
|
2005-01-12 |
2015-10-20 |
Ocular Research Of Boston, Inc. |
Dry eye treatment
|
ES2714900T3
(es)
|
2005-06-01 |
2019-05-30 |
Bioelectron Tech Corp |
Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
|
US20070060988A1
(en)
*
|
2005-07-18 |
2007-03-15 |
Grenon Stephen M |
Melting meibomian gland obstructions
|
US8083787B2
(en)
*
|
2005-07-18 |
2011-12-27 |
Tearscience, Inc. |
Method and apparatus for treating meibomian gland dysfunction
|
WO2013003594A2
(en)
|
2011-06-28 |
2013-01-03 |
Tearscience, Inc. |
Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
|
US20080114423A1
(en)
|
2006-05-15 |
2008-05-15 |
Grenon Stephen M |
Apparatus for inner eyelid treatment of meibomian gland dysfunction
|
US8950405B2
(en)
*
|
2006-05-15 |
2015-02-10 |
Tearscience, Inc. |
Treatment of obstructive disorders of the eye or eyelid
|
US7981095B2
(en)
*
|
2005-07-18 |
2011-07-19 |
Tearscience, Inc. |
Methods for treating meibomian gland dysfunction employing fluid jet
|
US7981145B2
(en)
|
2005-07-18 |
2011-07-19 |
Tearscience Inc. |
Treatment of meibomian glands
|
US20090043365A1
(en)
*
|
2005-07-18 |
2009-02-12 |
Kolis Scientific, Inc. |
Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
|
US7981146B2
(en)
*
|
2006-05-15 |
2011-07-19 |
Tearscience Inc. |
Inner eyelid treatment for treating meibomian gland dysfunction
|
WO2007058935A2
(en)
*
|
2005-11-14 |
2007-05-24 |
Bausch & Lomb Incorporated |
Ophthalmic composition for dry eye therapy
|
JP5374162B2
(ja)
|
2006-02-22 |
2013-12-25 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
|
US7745461B1
(en)
|
2006-02-27 |
2010-06-29 |
Alcon Research, Ltd. |
Method of treating dry eye disorders
|
ES2284398B2
(es)
|
2006-04-27 |
2008-12-16 |
Universidad Complutense De Madrid |
Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
|
US7981147B2
(en)
*
|
2006-05-15 |
2011-07-19 |
Tearscience, Inc. |
Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
|
US7976573B2
(en)
*
|
2006-05-15 |
2011-07-12 |
Tearscience, Inc. |
Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
|
US8007524B2
(en)
*
|
2006-05-15 |
2011-08-30 |
Tearscience, Inc. |
Heat treatment and heat loss reduction for treating meibomian gland dysfunction
|
US8137390B2
(en)
*
|
2006-05-15 |
2012-03-20 |
Tearscience, Inc. |
System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
|
US9314369B2
(en)
*
|
2006-05-15 |
2016-04-19 |
Tearscience, Inc. |
System for inner eyelid treatment of meibomian gland dysfunction
|
US8128673B2
(en)
|
2006-05-15 |
2012-03-06 |
Tearscience, Inc. |
System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
|
US8128674B2
(en)
|
2006-05-15 |
2012-03-06 |
Tearscience, Inc. |
System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
|
MX2008015151A
(es)
*
|
2006-07-07 |
2008-12-12 |
Bausch & Lomb |
Composiciones que comprenden un agonista del receptor glucocorticoide disociado y un agente inmunodepresor para tratar xeroftalmia.
|
WO2008027069A1
(en)
*
|
2006-08-21 |
2008-03-06 |
Tearscience, Inc. |
Method and apparatus for treating meibomian gland dysfunction employing fluid
|
US20080057022A1
(en)
*
|
2006-08-30 |
2008-03-06 |
Erning Xia |
Ophthalmic Pharmaceutical Compositions and Uses Thereof
|
US20080095863A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Alcon Manufacturing Ltd. |
2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
|
WO2008052037A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Alcon Research, Ltd. |
Packaging materials for formulations containing 2-pyrrolidone derivatives
|
US20080132475A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Charles Gerald Connor |
Treatment for dry eye
|
US20080188573A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Alcon Research, Ltd. |
Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
|
WO2008154129A1
(en)
*
|
2007-06-08 |
2008-12-18 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
|
USD617443S1
(en)
|
2008-02-06 |
2010-06-08 |
Tearscience, Inc. |
Eye treatment goggles
|
USD613408S1
(en)
|
2008-02-06 |
2010-04-06 |
Tearscience, Inc. |
Eye treatment head gear
|
US8314153B2
(en)
|
2008-09-10 |
2012-11-20 |
Edison Pharmaceuticals, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
US8539938B2
(en)
*
|
2009-03-12 |
2013-09-24 |
Ford Global Technologies, Llc |
Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
|
HUE037574T2
(hu)
|
2009-04-28 |
2018-09-28 |
Bioelectron Tech Corp |
Leber-féle örökletes optikus neuropátia és domináns optikus atrofia kezelése tokotrienol kinonokkal
|
USD638128S1
(en)
|
2009-10-06 |
2011-05-17 |
Tearscience, Inc. |
Ocular device design
|
TWI478730B
(zh)
*
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
US8658614B2
(en)
|
2010-08-13 |
2014-02-25 |
The University of Texas Health Science Center |
Aptamer-containing compositions and methods for targeting E-selectin
|
US9161531B2
(en)
|
2011-02-23 |
2015-10-20 |
Donald R. Korb |
High alcohol content sanitizer
|
RU2460517C1
(ru)
*
|
2011-07-14 |
2012-09-10 |
Федеральное государственное учреждение "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" |
Фармацевтическая композиция для комплексного лечения заболеваний глазной поверхности у больных с первичной открытоугольной глаукомой
|
US8859525B2
(en)
|
2011-07-19 |
2014-10-14 |
Bausch & Lomb Incorporated |
Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
|
RU2470630C1
(ru)
*
|
2011-07-28 |
2012-12-27 |
Общество с ограниченной ответственностью "Научно-производственная компания "ФАРМАСОФТ" (ООО "НПК "ФАРМАСОФТ") |
Средство для лечения воспалительных заболеваний глаз человека и животных, для стимуляции репаративных процессов и эпителизации
|
AU2012312816A1
(en)
|
2011-09-22 |
2014-04-24 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
US10842670B2
(en)
|
2012-08-22 |
2020-11-24 |
Johnson & Johnson Vision Care, Inc. |
Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
|
ES2942724T3
(es)
|
2013-04-30 |
2023-06-06 |
Alcon Inc |
Sistemas para el tratamiento de enfermedades del ojo
|
US9763827B2
(en)
|
2013-04-30 |
2017-09-19 |
Tear Film Innovations, Inc. |
Systems and methods for the treatment of eye conditions
|
EP3117210A4
(de)
|
2014-03-12 |
2017-11-01 |
University Of Virginia Patent Foundation |
Zusammensetzungen und verfahren zur behandlung von auegeninfektionen und -erkrankungen
|
EP3140316A1
(de)
|
2014-05-05 |
2017-03-15 |
Thetis Pharmaceuticals LLC |
Zusammensetzungen und verfahren im zusammenhang mit ionischen salzen von peptiden
|
CN107074884A
(zh)
|
2014-06-18 |
2017-08-18 |
西蒂斯制药有限责任公司 |
活性剂的矿物质氨基酸复合物
|
US20200383953A1
(en)
|
2015-11-05 |
2020-12-10 |
University Of Louisville Research Foundation, Inc. |
Local and regional anesthesia and analgesia
|
US10703701B2
(en)
|
2015-12-17 |
2020-07-07 |
Ptc Therapeutics, Inc. |
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
DK3454907T3
(da)
|
2016-06-03 |
2020-10-19 |
Thetis Pharmaceuticals Llc |
Sammensætninger og fremgangsmåder relateret til salte af specialiserede pro-løsningsmediatorer af inflammation
|
US10974063B2
(en)
|
2016-06-30 |
2021-04-13 |
Alcon Inc. |
Light therapy for eyelash growth
|
TW201938141A
(zh)
|
2018-02-21 |
2019-10-01 |
瑞士商諾華公司 |
基於脂質的眼用乳劑
|
US11141348B2
(en)
|
2018-02-26 |
2021-10-12 |
Olympic Ophthalmics, Inc. |
Treatment methods using handheld devices for disorders
|
US11464672B2
(en)
|
2018-06-01 |
2022-10-11 |
Aurora Tears Technology, Inc. |
Systems and methods for generating and applying biomimicry tear films
|
US11253395B2
(en)
|
2018-06-01 |
2022-02-22 |
Aurora Tears Technology, Inc. |
Systems and methods for generating and applying biomimicry tear films
|
US11278493B2
(en)
|
2018-12-10 |
2022-03-22 |
EternaTear, Inc. |
Ophthalmic formulations providing durable ocular lubrication
|
EP4104817A1
(de)
|
2021-06-17 |
2022-12-21 |
Skeye Pharma GbR |
Ophthalmische zusammensetzung mit astragalosid iv
|
EP4104818A1
(de)
|
2021-06-17 |
2022-12-21 |
Skeye Pharma GbR |
Ophthalmische zusammensetzung mit xanthohumol
|
US11679078B1
(en)
|
2022-03-08 |
2023-06-20 |
EternaTear, Inc. |
Ophthalmic formulations and related methods
|
US11471475B1
(en)
|
2022-03-08 |
2022-10-18 |
Ralph P. Stone |
Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
|
WO2023187672A1
(en)
|
2022-03-31 |
2023-10-05 |
Alcon Inc. |
Ophthalmic compositions
|
EP4302767A1
(de)
|
2022-07-04 |
2024-01-10 |
Skeye Pharma GmbH |
Ophthalmische zusammensetzung die eriocnitrin umfasst
|